With the advent of high-throughput sequencing and refined RNA modification profiling techniques—such as selective immunoprecipitation, LC-MS/MS quantification, and chemical-based site mapping—the significance of METTL1 and m7G modifications in tumor biology has become increasingly evident. The gene discussed is METTL1; the disease is neoplasm.